EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Potent and Selective Oxidatively Labile Ether‐Based Prodrugs through Late‐Stage Boronate Incorporation

Paul J Geaneotes iD, Chasity P Janosko, Cephas Afeke, Alexander Deiters iD, Paul E Floreancig iD

Angewandte Chemie International Edition · 2024-10 · 63 (40)

DOI: 10.1002/anie.202409229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 02.09.2024. Verfasst von Paul J Geaneotes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania, 15260, USA. Hauptthemen laut MEDLINE: Prodrugs, Oxidation-Reduction, Ethers, Boronic Acids. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This manuscript describes a new strategy for prodrug synthesis in which a relatively inert ether group is introduced at an early stage in a synthetic sequence and functionalized in the final step to introduce a prodrug‐activating group through a chemoselective process. Boryl allyloxy (BAO) ether groups are synthesized through several metal‐mediated processes to form entities that are readily cleaved under oxidative conditions commonly found in cancer cells. The high cleavage propensity of the BAO group allows for ether cleavage, making these compounds substantially more hydrolytically stable in comparison to acyl‐linked prodrugs while retaining the ability to release alcohols. We report the preparation of prodrug analogues of the natural products camptothecin and pederin from acetal precursors that serve as protecting groups in their synthetic sequences. The BAO acetal groups cleave in the presence of hydrogen peroxide to release the cytotoxic agents. The pederin‐based prodrug shows dramatically greater cytotoxicity than negative controls and outstanding selectivity and potency toward cancer cell lines in comparison to non‐cancerous cell lines. This late‐stage functionalization approach to prodrug synthesis should be applicable to numerous systems that can be accessed through chemoselective processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsOxidation-ReductionEthersBoronic AcidsHumansAntineoplastic AgentsCell Line, TumorDrug Screening Assays, AntitumorMolecular StructureCell Proliferation

Stichwörter der Autor:innen

BoronCytotoxicityMetathesisOxidationProdrugs

Substanzen

ProdrugsEthersBoronic AcidsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania, 15260, USA.

ORCID-Profile: Paul J Geaneotes, Alexander Deiters, Paul E Floreancig

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Geaneotes, P. J., Janosko, C. P., Afeke, C., Deiters, A., & Floreancig, P. E. (2024). Potent and Selective Oxidatively Labile Ether‐Based Prodrugs through Late‐Stage Boronate Incorporation. Angewandte Chemie International Edition, 63(40). https://doi.org/10.1002/anie.202409229

Vancouver

Geaneotes PJ, Janosko CP, Afeke C, Deiters A, Floreancig PE. Potent and Selective Oxidatively Labile Ether‐Based Prodrugs through Late‐Stage Boronate Incorporation. Angewandte Chemie International Edition. 2024;63(40). doi:10.1002/anie.202409229

BibTeX
@article{Geaneotes2024,
  author = {Geaneotes, Paul J and Janosko, Chasity P and Afeke, Cephas and Deiters, Alexander and Floreancig, Paul E},
  title = {Potent and Selective Oxidatively Labile Ether‐Based Prodrugs through Late‐Stage Boronate Incorporation},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  volume = {63},
  number = {40},
  doi = {10.1002/anie.202409229}
}
Kostenlos starten →